OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective
Ranran Wang, Tianyi Yuan, Jianmei Wang, et al.
Pharmacological Research (2022) Vol. 180, pp. 106238-106238
Closed Access | Times Cited: 63

Showing 26-50 of 63 citing articles:

Natural Targeting Potent ROS‐Eliminating Tungsten‐Based Polyoxometalate Nanodots for Efficient Treatment of Pulmonary Hypertension
Hong Liu, Shuya Wang, Qiaohui Chen, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 22
Closed Access | Times Cited: 8

Periodontitis exacerbates pulmonary hypertension by promoting IFNγ+ T cell infiltration in mice
Xiao-Qian Meng, Lin‐Juan Du, Shuo Xu, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2

A peripheral system disease—Pulmonary hypertension
Yang Sun, Chen Chen, Yan Qian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116787-116787
Open Access | Times Cited: 2

Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension
Adam Olaitan Abdulkareem, Priya Tiwari, Zahid Rasool Lone, et al.
European Journal of Pharmacology (2023) Vol. 943, pp. 175558-175558
Closed Access | Times Cited: 6

The Role of Inflammation in The Cellular and Molecular Mechanisms of Cardiopulmonary Complications of Sickle Cell Disease
Oluwabukola T. Gbotosho, Jahnavi Gollamudi, Hyacinth I. Hyacinth
Biomolecules (2023) Vol. 13, Iss. 2, pp. 381-381
Open Access | Times Cited: 6

Transcription factors and potential therapeutic targets for pulmonary hypertension
Yang Liu, Naifu Wan, Fanpeng Gong, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 6

Myeloid-derived suppressor cells and pulmonary hypertension
Hui Zhang, Qiwei Li, Yuanyuan Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6

CC chemokines Modulate Immune responses in Pulmonary Hypertension
Qian Yan, Shasha Liu, Yang Sun, et al.
Journal of Advanced Research (2023) Vol. 63, pp. 171-186
Open Access | Times Cited: 6

Inhibiting IL-6 in medicine: a new twist to sustain inhibition of his cytokine tin the therapy of Pulmonary Arterial Hypertension
Enrico Gugliandolo, Francesco Macrı̀, Roberta Fusco, et al.
Pharmacological Research (2023) Vol. 192, pp. 106750-106750
Open Access | Times Cited: 4

Expression of Inflammatory Genes in Murine Lungs in a Model of Experimental Pulmonary Hypertension: Effects of an Antibody-Based Targeted Delivery of Interleukin-9
Judith Heiß, Katja Grün, Isabell Singerer, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 1, pp. 27-35
Open Access | Times Cited: 1

No genetic causal association between iron status and pulmonary artery hypertension: Insights from a two‐sample Mendelian randomization
Pengcheng Liu, Meng‐Na Lv, Yanyan Rong, et al.
Pulmonary Circulation (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 1

Exploring the mechanisms of glycolytic genes involvement in pulmonary arterial hypertension through integrative bioinformatics analysis
Yu-Xuan Lou, Erdan Shi, Rong Yang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access | Times Cited: 1

Establishment of a prediction model of pulmonary artery hypertension in patients with hyperthyroidism
Tianhui Yan, Qiang Ma, Xin Li, et al.
Annals of Noninvasive Electrocardiology (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 1

The Role of Gut and Airway Microbiota in Pulmonary Arterial Hypertension
Linlin Huang, Hongdie Zhang, Yijun Liu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 7

Novel p38 Mitogen-Activated Protein Kinase Inhibitor Reverses Hypoxia-Induced Pulmonary Arterial Hypertension in Rats
Grazielle Fernandes Silva, Jaqueline da Silva, A Alencar, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 900-900
Open Access | Times Cited: 6

The Systolic Pulmonary Arterial Pressure Liaises Impaired Cardiac Autonomic Control to Pro-inflammatory Status in Systemic Sclerosis Patients
Gabriel Dias Rodrigues, Marco Vicenzi, Chiara Bellocchi, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 3

Sleep-related disorders in patients with precapillary pulmonary hypertension
Hsin-Yu Chao, Brendon J. Yee, Chih‐Hsin Hsu, et al.
Sleep Medicine Reviews (2024) Vol. 77, pp. 101972-101972
Closed Access

Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management
Yihan Zhang, Xing Li, Shang Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8427-8427
Open Access

Scroll to top